Pseudophakic Astigmatic Reduction With Verion-LenSx Arcuate Incisions
NCT ID: NCT02763124
Last Updated: 2019-11-01
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2016-05-31
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Femtosecond Laser-assisted Arcuate Incisions Versus Manual Arcuate Incisions Outcomes
NCT04126174
Arcuate Incisions With Light Adjustable Lens for Astigmatism Correction in Lens Surgery
NCT07140653
Accuracy of LASIK Flaps Created With the LenSx® Femtosecond Laser - A Pilot Study
NCT02575911
Astigmatism Correction With Intrastromal Arcuate Incisions in Eyes Undergoing Cataract Surgery With Femtosecond Laser Using the Cassini Ambient With Iris Registration (ARCUATAS)
NCT05053620
Safety and Effectiveness of Arcuate Incisions Performed With the iFS Femtosecond Laser System
NCT01348854
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Verion-LenSx
The Verion-LenSx femtosecond laser system will be used to perform one or two corneal arcuate incisions.
Verion-LenSx
The Verion-LenSx femtosecond laser system will be used to create one or two partial-depth corneal arcuate incisions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Verion-LenSx
The Verion-LenSx femtosecond laser system will be used to create one or two partial-depth corneal arcuate incisions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing and able to provide informed consent for participation in the study.
Exclusion Criteria
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon, a Novartis Company
INDUSTRY
Gainesville Eye Associates
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Clayton Blehm, MD
PI
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clayton Blehm, MD
Role: PRINCIPAL_INVESTIGATOR
Gainesville Eye Associates
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gainesville Eye Associates
Gainesville, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CB-16-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.